Loại tài liệu:    Chỉ tìm trong: 
31-40 trong số 117 kết quả
Insights into Clinical Trials for Drugs Targeting MASLD: Progress, Challenges, and Future Directions
Tác giả: Yu Wu, Pu Dong, Qifang Wu, Ya Zhang, Gang Xu, Chenwei Pan, Haibin Tong
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  794.147
 
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease
Tác giả: Luis Antonio Diaz, Sheldon Morris, Grant Miller, Raquel Carvalho-Gontijo Weber, Jeremiah D Momper, Feng He, Sonia Jain, Catriona Jamieson, Tatiana Kisseleva, David Brenner, Rohit Loomba, Shravan Dave, Susy M Kim, Wathnita Sarik, Lisa Richards, Egbert Madamba, Ricki Bettencourt, Christian Fulinara, Thuy Pham
Xuất bản: England: Alimentary pharmacology & therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  352.233
 
Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity
Tác giả: Maud Maillard, Jenny Q Nguyen, Smita Bhatia, Seth E Karol, Federico G Antillon-Klussmann, Cyrine E Haidar, Deepa Bhojwani, Jun J Yang, Wenjian Yang, Keito Hoshitsuki, Mary V Relling, Kelly E Caudle, Kristine R Crews, Sima Jeha, Hiroto Inaba, Ching-Hon Pui
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  160
 
Clinical Evidence 2030
Tác giả: Peter Arlett, Denise Umuhire, Frank Pétavy, Steffen Thirstrup, Maria Lamas, Emer Cooke, Karl Broich, Patrice Verpillat, Paolo Foggi, Ulla Wändel Liminga, Bruno Sepodes, Marianne Lunzer, Brian Aylward, Spiros Vamvakas, Kit Roes
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  333.822
 
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease
Tác giả: Luis Antonio Diaz, Ricki Bettencourt, David Brenner, Raquel Carvalho-Gontijo Weber, Shravan Dave, Christian Fulinara, Feng He, Sonia Jain, Catriona Jamieson, Susy M Kim, Tatiana Kisseleva, Rohit Loomba, Egbert Madamba, Grant Miller, Jeremiah D Momper, Sheldon Morris, Thuy Pham, Lisa Richards, Wathnita Sarik
Xuất bản: England: Alimentary pharmacology & therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  616.515
 
Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha-2-Delta Ligand PD-217,014 in Patients With Irritable Bowel Syndrome
Tác giả: Lesley A Houghton, Simiao Gao, Steven A Gilbert, Benoit Coffin, Magnus Simren, Jeremy D Gale
Xuất bản: England: Alimentary pharmacology & therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  338.9
 
Clinical Course and Prognosis of Long-Term Survivors of Hepatocellular Carcinoma
Tác giả: Soon Sun Kim, Jonghyun Lee, Sang Bong Ahn, Young Eun Chon, Eileen Yoon, Soung Won Jeong, Dae Won Jun
Xuất bản: England: Alimentary pharmacology & therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  333.822
 
Implementing Pharmacogenomics Clinical Decision Support: A Comprehensive Tutorial on how to Integrate the Epic Genomics Module
Tác giả: Bradley T Hall, Eda Eken, Larisa H Cavallari, Julio D Duarte, Kristin W Wiisanen, Emily J Cicali, Khoa A Nguyen
Xuất bản: United States: Clinical pharmacology and therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  286.131
 
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor: Authors' Reply
Tác giả: Kee Huat Chuah, Sanjiv Mahadeva
Xuất bản: England: Alimentary pharmacology & therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  133.5266
 
Letter: Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor
Tác giả: Shoko Miyahara, Takeshi Yamashina, Takehiro Ohyama, Masahiro Banno
Xuất bản: England: Alimentary pharmacology & therapeutics , 2025
Bộ sưu tập: NCBI
ddc:  133.5266
 

Truy cập nhanh danh mục